Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Therapeutic agents targeting apolipoprotein B The decreasing ApoB levels by statin therapy were associated with NIRS-derived lipid-rich plaques regression and IVUS-derived plaque burden regression 109,110
In this study, HepG2 cells transiently transfected with the human GSTP1 construct were utilized to investigate the protective effect of GSTP1 in a cellular context
Eli Lilly: Tirzepatide/Mounjaro Lily initially developed Tirzepatide as a dual agonist, with a half-life of around 5 days, for the treatment of T2DM
Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis
US$ 23.80
US$ 23.94
US$ 21.66
US$ 27.56
US$ 25.31
US$ 28.95
US$ 26.94
US$ 28.06
